Logo image of HNGE

HINGE HEALTH INC-A (HNGE) Stock Fundamental Analysis

NYSE:HNGE - New York Stock Exchange, Inc. - US4333131039 - Common Stock - Currency: USD

55.56  -4.79 (-7.94%)

Fundamental Rating

4

Taking everything into account, HNGE scores 4 out of 10 in our fundamental rating. HNGE was compared to 103 industry peers in the Health Care Providers & Services industry. No worries on liquidiy or solvency for HNGE as it has an excellent financial health rating, but there are worries on the profitability. While showing a medium growth rate, HNGE is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

In the past year HNGE has reported negative net income.
In the past year HNGE had a positive cash flow from operations.
HNGE Yearly Net Income VS EBIT VS OCF VS FCFHNGE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2023 2024 0 -50M -100M

1.2 Ratios

HNGE's Return On Assets of -1.67% is in line compared to the rest of the industry. HNGE outperforms 42.72% of its industry peers.
HNGE has a Return On Equity of -2.72%. This is comparable to the rest of the industry: HNGE outperforms 49.51% of its industry peers.
Industry RankSector Rank
ROA -1.67%
ROE -2.72%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
HNGE Yearly ROA, ROE, ROICHNGE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2023 2024 -5 -10 -15 -20 -25

1.3 Margins

With an excellent Gross Margin value of 77.00%, HNGE belongs to the best of the industry, outperforming 91.26% of the companies in the same industry.
The Profit Margin and Operating Margin are not available for HNGE so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 77%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
HNGE Yearly Profit, Operating, Gross MarginsHNGE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2023 2024 0 20 -20 40 -40 60

More info and screens

8

2. Health

2.1 Basic Checks

HNGE does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, HNGE has about the same amount of shares outstanding.
HNGE has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
HNGE Yearly Shares OutstandingHNGE Yearly Shares OutstandingYearly Shares Outstanding 2023 2024 20M 40M 60M
HNGE Yearly Total Debt VS Total AssetsHNGE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2023 2024 200M 400M 600M

2.2 Solvency

HNGE has an Altman-Z score of 10.35. This indicates that HNGE is financially healthy and has little risk of bankruptcy at the moment.
HNGE has a Altman-Z score of 10.35. This is amongst the best in the industry. HNGE outperforms 93.20% of its industry peers.
HNGE has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 10.35
ROIC/WACCN/A
WACC8.86%
HNGE Yearly LT Debt VS Equity VS FCFHNGE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2023 2024 0 100M 200M 300M 400M

2.3 Liquidity

A Current Ratio of 2.31 indicates that HNGE has no problem at all paying its short term obligations.
Looking at the Current ratio, with a value of 2.31, HNGE is in the better half of the industry, outperforming 79.61% of the companies in the same industry.
A Quick Ratio of 2.26 indicates that HNGE has no problem at all paying its short term obligations.
With a decent Quick ratio value of 2.26, HNGE is doing good in the industry, outperforming 78.64% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.31
Quick Ratio 2.26
HNGE Yearly Current Assets VS Current LiabilitesHNGE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2023 2024 100M 200M 300M 400M 500M

More info and screens

5

3. Growth

3.1 Past

HNGE shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 88.96%, which is quite impressive.
HNGE shows a strong growth in Revenue. In the last year, the Revenue has grown by 33.37%.
EPS 1Y (TTM)88.96%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-228.89%
Revenue 1Y (TTM)33.37%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%49.71%

3.2 Future

The Earnings Per Share is expected to grow by 110.38% on average over the next years. This is a very strong growth
Based on estimates for the next years, HNGE will show a very strong growth in Revenue. The Revenue will grow by 23.27% on average per year.
EPS Next Y529.27%
EPS Next 2Y164.04%
EPS Next 3Y110.38%
EPS Next 5YN/A
Revenue Next Year33.58%
Revenue Next 2Y26.53%
Revenue Next 3Y23.27%
Revenue Next 5YN/A

3.3 Evolution

HNGE Yearly Revenue VS EstimatesHNGE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2023 2024 2025 2026 2027 200M 400M 600M
HNGE Yearly EPS VS EstimatesHNGE Yearly EPS VS EstimatesYearly EPS VS Estimates 2025 2026 2027 0.2 0.4 0.6 0.8 1

More info and screens

3

4. Valuation

4.1 Price/Earnings Ratio

HNGE reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
HNGE is valuated quite expensively with a Price/Forward Earnings ratio of 73.04.
HNGE's Price/Forward Earnings ratio is in line with the industry average.
HNGE is valuated expensively when we compare the Price/Forward Earnings ratio to 35.28, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE N/A
Fwd PE 73.04
HNGE Price Earnings VS Forward Price EarningsHNGE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 -100 -200 -300

4.2 Price Multiples

Compared to the rest of the industry, the Price/Free Cash Flow ratio of HNGE is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 52.22
EV/EBITDA N/A
HNGE Per share dataHNGE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3 4 5

4.3 Compensation for Growth

HNGE's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as HNGE's earnings are expected to grow with 110.38% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y164.04%
EPS Next 3Y110.38%

More info and screens

0

5. Dividend

5.1 Amount

HNGE does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

HINGE HEALTH INC-A

NYSE:HNGE (8/8/2025, 1:31:59 PM)

55.56

-4.79 (-7.94%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)08-05 2025-08-05/amc
Earnings (Next)N/A N/A
Inst Owners7.79%
Inst Owner ChangeN/A
Ins Owners75.36%
Ins Owner Change-1528.14%
Market Cap4.33B
Analysts83.16
Price Target50.83 (-8.51%)
Short Float %17.63%
Short Ratio1.37
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)7.04%
PT rev (3m)N/A
EPS NQ rev (1m)0.76%
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)-0.34%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 73.04
P/S 11.1
P/FCF 52.22
P/OCF 50.06
P/B 9.88
P/tB 11.67
EV/EBITDA N/A
EPS(TTM)-0.15
EYN/A
EPS(NY)0.76
Fwd EY1.37%
FCF(TTM)1.06
FCFY1.91%
OCF(TTM)1.11
OCFY2%
SpS5
BVpS5.62
TBVpS4.76
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -1.67%
ROE -2.72%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 77%
FCFM 21.26%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-ScoreN/A
Asset Turnover0.55
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA N/A
Cap/Depr 63.5%
Cap/Sales 0.92%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.31
Quick Ratio 2.26
Altman-Z 10.35
F-ScoreN/A
WACC8.86%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)88.96%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-228.89%
EPS Next Y529.27%
EPS Next 2Y164.04%
EPS Next 3Y110.38%
EPS Next 5YN/A
Revenue 1Y (TTM)33.37%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%49.71%
Revenue Next Year33.58%
Revenue Next 2Y26.53%
Revenue Next 3Y23.27%
Revenue Next 5YN/A
EBIT growth 1Y81.28%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year256.65%
EBIT Next 3Y85.62%
EBIT Next 5YN/A
FCF growth 1Y166.01%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y176.68%
OCF growth 3YN/A
OCF growth 5YN/A